Charity regSstration number NIC100784 (Northem Ireland)
NORTHERN IRELAND RHEUMATISM TRUST
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

NORTHERN IRELAND RHEUMATISM TRUST
LEGAL AND ADMINISTRATIVE INFORMATION
Trustees
Dr G Wright
DrA Taggart
MsAQuinn
Ms H McKeeman
DrACaims
DrA Bell
Dr E Ball
Mr R Kelly
DrA Pendleton
Ms J Monaghan
Charity nurnber {Northern Ireland)
NIC100784
Principal address
Department of Rheumatology
Musgrave Path HDspitsI
Stod(mans Lane
Belfast
BT9 7JB
Independent examlner
GMCG LISBURN
Century House
40 Crescent Buslness Park
Lisbum
BT28 2GN
Banker5
Ulsler Bank Limtted
911 g3 Universtiy Road
Belfast
BT7 1NG

NORTHERN IRELAND RHEUMATISM TRUST
CONTENTS
Page
TTUStees' report
Independent exarninels report
ststement of financial activities
ststemenl of financial positson
Notes to the finanual statements
7-12

NORTHERN IRELAND RHEUMATISM TRUST
TRUSTEES. REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
The trustees present their annual report and financlal statements for the year ended 31 December 2024.
The financial stalemenls have been prepared in accordance with the accounting polictes set out in note 1 to the
financial statements and comply with the charity's Trust Deed, the Charities Act (Northern Ireland) 2008 and
"Accountin9 and Reporting by Charities.. Statement of Recommended Practice applicable to charities preparlng
their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland
IFRS 1021 leffeclive 1 January 20191"
Objectives and activities
The charity's objects include all aspects of education and training, for all medical, nursing and allSed health
professionals working in the field of rheumatic disease within Northern Ireland.
Activities carried out by the organi5alion supports medical, nursing and allied health professionals working in the
rield of rheumatology in Northern Ireland to attend training and edu¢ational conferences to benchmark, netsvork,
gain knowledge, skills and expertise in the field of rheumatology. The organisation also critically reviews and
fiJnds appropriate research projects within the field of rheumatology in Northern Ireland.
The trustees have paid due regard lo guidance issued by the Charity Commission in deciding what aclNrties the
charity should undertake.
Achlevements and perfomiance
The charity cgntinues to support research and education amongst healthcare professionals who are involved in
the care of patients with rheumatic disease within Northern Ireland.
The charity has been able to support the training of medical professionals during this year. through the generous
funding received from Novartis and other donors.
Flnancial review
The company had nel income in the year of £8,32812023 - net expenditure £8,146), leaving unre51ricted funds of
£170.809 (2023 £159.075) and reslricled funds of £5,832 (2023 £9,238). The unrestricted funds are
considered to be essential to provide sufficient funds lo cover any unforeseen costs which may arise and fulfil
legal obligations of the charity in the event that current levels of income are not rnaintained.
It is the policy of the charity that unrestricted funds which have not been designated for a specific use should be
maintained at a level eqtjivalent to between three and six month's expenditure. The trustees consider Ihal
reserves al this level will ensure that, in the event of a significant drop in funding. they will be able to continue the
charity's current activities while consideration is given to ways in which additlonal funds may be raised. This level
of reserves has been maintained throughout the year.
The trustees have assessed the major risks lo which the charity is exposed, and are satisfied that Systems are in
place to miligale exposure to the major risks.

NORTHERN IRELAND RHEUMATISM TRUST
TRUSTEES. REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
structure, govemance and management
The charity was established by a charitable trust deed on 14 December 1992.
The trustees who gerved during the year and up to the date of signature of the financial statements were-
Dr G Wright
Dr A Taggart
M5 A Quinn
Ms H McKeeman
DrA Cairns
DrABell
Dr E Ball
Mr R Kelly
DrA Pendleton
Ms J Monaghan
The trustees shall elect from among their number the following Honorary Officers in each year at the annual
general meeting; Chaimian, Honorary Secrelary and Honorary Treasurer.
There is to be not less than three or more than tsvelve trustees at any time.
TTUStees are appointed at the disGretion of existing trustees.
The trustees. report was approved by the Board of Trustees.
Ms A Quinn
Ttustee
Dated: .

NORTHERN IRELAND RHEUMATISM TRUST
INDEPENDENT EXAMINER'S REPORT
TO THE TRUSTEES OF NORTHERN IRELAND RHEUMATISM TRUST
We report to the Irustees on our examination of the financial statement5 of Northem Ireland Rheumatism Trust
(the charity) for the year ended 31 Decembei 2024.
Responsibilities and basls of report
As the charity's trustees you are responsible for the preparation of the accounts in accordance with the
Charitses Act (Northern Ireland) 2008.
11 is our responsibility to=
examine the account5 under section 65 of the Charities Act (Northern Ireland} 2008.,
follow the procedures laid down in the general Directions given by Ihe Charity Commission for Northern
Ireland under section 6519}Ibl of the Charities A¢t', and
stale whether particular matters have come lo our attention.
Basis of independent examlnerfs report
We have examined your charity account5 as required under section 65 of the Charities Act and our
examination was carried out in accordance with the general Dire¢tion5 given by the Charity Commisslon for
Northem Ireland under section 6519){bl of the Charitles Act.
Our examination included a review of the accounting records kept by the charity and a comparison of the
accounts presented with those records. It also included consideration of any unusual items or disclosures in
the accovnls and seekir¢g explanations from you as charity trustees concerning any such matters.
Our role is lo slate whether any material matters have come to our attention glving us cause to believe-.
That accounting records were not kept in accordance with section 63 of the Charities Act
That the a¢￿￿nts do not accord with those accounting records
That the accouE7ts do not comply with the accounting requirements of the Charities Act
That Ihere is further information needed for a proper understanding of the accounts lo be reached.

NORTHERN IRELAND RHEUMATISM TRUST
INDEPENDENT EXAMINER'S REPORT (CONTINUED)
TO THE TRUSTEES OF NORTHERN IRELAND RHEUMATISM TRUST
Independent examine￿$ slatement
We have completed our examination and have no concems in respect of the matters (l) to {4) listed above
and, in connection w¢th following the Directions of the Chartty Commission for Northem Ireland, we have found
no matters that requi￿ drawing to your attention.
GMCG LISBURN
Century House
40 Crescent Business Park
Lisbum
BT28 2GN
Dated:

NORTHERN IRELAND RHEUMATISM TRUST
STATEMENT OF FINANCIAL ACTIVITIES
INCLUDING INCOME AND EXPENDITURE ACCOUNT
FOR THE YEAR ENDED 31 DECEMBER 2024
Unrestricted Restricted
funds
funds
2024
2024
Totsl Unrestrlcted Restrleted
funds
funds
2023
2023
Total
2024
2023
Notes
Income and endowments from:
Donations and legacies
Investmen15
other income
27,580
2,762
200
27.580
2,762
200
27.015
2,265
27,015
2,265
Totsl Income
30,542
30.542
29,280
29,280
Expendlture on:
Charitable activities
22.214
22,214
37,426
37,426
Total expenditure
22.214
22,214
37,426
37,426
Net incomellexp8nditurel
8.328
8,328
18,1461
(8.146)
Transfers betsveen
funds
3,406
{3,406)
Net movoment In
fundg
11,734
13,4C6)
8,328
18,1461
18,1461
Reconclllation of funds..
Fund balances al 1 January
2024
159.075
9,238
168,313
167,221
9,238
176.459
Fund balances at 31
December 2024
170,809
5.832
176,641
159,075
9,238
168,313
The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure
derive from continulng activities.

NORTHERN IRELAND RHEUMATISM TRUST
STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2024
2024
2023
Notes
Current assets
Debtors
Cash at bank and in hand
10
355
174,265
180.453
180,453
174.620
Creditors: amounts falling due within
one year
11
13.812)
(6,30n
Net cu￿ent assets
176,641
168.313
Income funds
Restricted fiJnds
Unrestricted fvnds
12
13
5,832
170,809
9,238
159,075
176.641
168.313
The financial statements were approved by the Trustees. authorised for issue on
their behalf by.,
and signed on
DrGWri
Trustee

NORTHERN IRELAND RHEUMATISM TRUST
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
Accounting pollcies
Charity infomiation
Northern Ireland Rheumatism Trust is an unincorporated charity registered with the Charity Commission In
Northern Ireland. The principal office is Department of Rheumatology, Musgrave Park Hospital, Stockmans
Lane, Belfast, BT9 7JB.
1.1 Accounting convention
The finan¢ial statements have been prepared in accordance with Ihe charity's conslilution, the Charities Act
2011 and "Acctsunling and Reporting by ChaTlties'. Statement of Recommended Practice applicable to
charlties preparing Iheir accounts in accordance with the Financial Reporting Standard applicable in the UK
and Republic of Ireland {FRS 102). (as amended for accounting periods commencing from 1 January 2016).
The charity is a Public Benefii Entity as defined by FRS 102.
The charity has taken advantage of the provisions in the SORP for charrties appiying FRS 102 Update Bulletin
1 not lo prepare a Statement of Cash Flows.
The finanaal statements are prepared in sleriing, which is the functional currency of the charity. Monetary
amounts in these financial statemenls are rounded lo the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting
policies adopted are set out below.
1.2 Golng concern
At the time of approving the financial statements, the Iruslees have a reasonable expectation Ihal the charity
has adequate resource5 to continue in operational exislence for the foreseeable fulure. Thus the trustee5
continue lo adopt the going concern basis of a¢counting in preparing the fir¢ancial statements.
1.3 Charitable funds
Unrestricted funds are available for use at the discretion of the trustees in furtherance of treir charitable
objective5.
Resiricted funds are subject lo specific condiliDns by donors or grantors as lo how they may be used. The
purposes and uses of the restricted funds are set out in the notes to Ihe financial statements.
1.4 Incoming resources
Income is recognised when the charity is legally entitled lo it after any performance conditions have been met,
the amount5 can be measured reliably. and it is probable that income will be received.
Cash donations are recognised Dn receipt. Other donations are recognised once the charity has been noufied
of the donation, unless performance condilions require deferral of the amount. Income tax recoverable in
relation to donations received under Grft Aid or deeds of covenant is recognised at the time of the donation.
1.5 Re50urees expended
Expenditure is recognised on an accrual basis as a liability is incurred.
Charrtable expenditure comprises those cosls incurred by the charity in the delivery of ils activities and
setvices for Its beneficiaries. 11 includes both costs that can be allocated directly lo such activities and those
costs of an indirect nature to support them.
1.6 Cash and cash equivalents
Cash and cash equivalents include cash in hand, deposits held al call with banks, other short-temi liquid
investments with original maturiiies of three months or less, and bank overdrafts. Bank overdrafts are shown
within borrowings in current liabilities.

NORTHERN IRELAND RHEUMATISM TRUST
NOTES TO THE FINANCIAL STATEMENTS {CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
Accounting policies (Continued)
1.7 Financial instruments
The charity has elected to apply the provisions of Section 11 '8asie Finan¢tal Instruments, and Section 12
'Other Financial Instruments Issues. of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the charity's balance sheet when the charity becomes paty to the
contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statemeftts, when
there is a legally enforceable rigm to set off the recognised amounts and Ihere is an intention to settle on a net
basis or to realise the asset and settle the liability sirnultaneously.
Basic financffal assets
Basic financial assets. which include debtors and cash and bank balances, are initially rneaSv￿d at
transadion pri￿ including transaction costs and are subsequently carrted at amortised cost Using the effective
interest method unless the arrangement constitutes a firTancing transaction, where the transactton is
measured at the present value of the future receipts discounted at a market rate of interest. Financial assets
ctassified as re￿1vable within one year are not amortised.
Basic financial liabiliti05
Basi¢ financial liabilities, including creditors and bank loans are initially recognised at transaction price unless
the aTrangement constitutes a financing transaction, where the debt instrument is mtrasured at the present
value of the future payments discounted al a market rate of inte￿st. Financial liabilities classified as payable
within one year are not amortised.
Debt in5trumenls are subsequently carrÈed at amortised cos( using the effective interest rate method.
Trade creditors are obligation5 to pay for goods or seNices that have been acquired in the ordinary course of
operations from suppliers. Amounts payable are classified as current liabilities rf payment is due within one
year or less. If not, they are presented as non-ojrrent liabilities. Trade Creditors are recognised initialty at
transaction price and subsequently measured at amortised cost using the effective interest method.
Derecognition of financial liabilities
Financial Ilabilities are derecognised when the charity's contractual obligations expire or are dischar9ed or
ancelled.
Income from donations and legacies
Unrestricted
funds
2024
Unrestricted
funds
2023
Donations and gifts
27,580
27,015

NORTHERN IRELAND RHEUMATISM TRUST
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THEYEAR ENDED 31 DECEMBER 2024
Income from investrnents
Unrestricted Unrestrfcted
funds
funds
2024
2023
Interest receivable
2,762
2.265
Other Income
Unrestrlcted Unrestricted
funds
funds
2024
2023
Other income
200
Expenditure on charitable activltles
2024
2023
Direct Costs
Training
Database collection costs
Bank charges
Accountsncy
8.672
12.432
36,266
20
1,140
1,110
22.214
37.426
Analysis by fund
Unrestricted funds
22.214
37.426
Des¢rlption of Charitable actlvlties
Education, training. care and research into rheumatic and arthrsti"c disorders.
Trustees
During the year ended 31 December 2024 no payments were made lo trustees oflhe ttharity-
Taxatlon
The charity is exempt from taxation on its activities because all it5 income is applied for charitable purposes.

NORTHERN IRELAND RHEUMATISM TRUST
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
Transfers
During the year the trustees transferred £3,406 from restrtcted funds to unrestricted funds for unspent funds.
This was within Ihe tenns of the restricted funds provided.
10 Debtors
2024
2023
Amounts falling due within one year:
Prepayments and accrued income
355
11 Creditors: amounts falllng due within one year
2024
2023
Accnjals and deferred income
3,812
6.307
12 Restricted funds
The restricted funds of the charity comprise the unexpended balances of donations and grants held on trust
subject to specific conditions by donors as to how they may be used.
At 1 January
2024
Transfers
At31
December
2024
Training - Abbvie Ltd
Training - Roche Products
Telemedicine- Abbwie Ltd
Training - Novartis Inveslment
1.970
866
5,832
570
(1.970)
(866)
5,832
(570)
9,238
(3,406)
5,832
10-

NORTHERN IRELAND RHEUMATISM TRUST
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
12 Restricted funds (Continued)
Previous year:
At 1 January
2023
Transfers
At31
Decernber
2023
Training - Abbvie Ltd
Training - Roche Products
Telemedicine- Abbvie Ltd
Training- Novartis Investment
1,970
866
5,832
570
1,970
866
5,832
570
9,238
9,238
Trainin
-AbbVie Ltd
Funding received for training course on developing skills in musculoskeletal ultrasound.
Trainin
- Roche Products
Funding received for Vas¢ulilis meeting which Roche Products sponsored.
Telemedicine - Abbvle Ltd
Funding received for IT equipmenl for patient self-monitoring which wll benefit patientsl and or the NHS by
improving technology and patient education.
Trainin
- Novartis Investment
Funding received for training course on developing skills in musculoskeletal ultrasound with emphasis on the
differential di8gnosis of musculoskelelal pathology and the practical use of ultrasound in diagnosis, treatment
and monitoring of patients Wlth rhevmatic disease.
13 Unrestricted funds
The unrestricted funds of the challty comprise the unexpended balances of donations and grants which are
not subject lo specific conditions by donors and grantors as to how they may be used. These include
designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes.
At l January
2024
Incoming
re$ourcgS
Resources
expended
Transfers
At31
December
2024
General funds
159,075
30,542
122,2141
3,406
170,809
Previous year:
Ai 1 January
2023
Incoming
resources
Resources
expended
Transfers
At31
December
2023
General funds
167,221
29,280
137.4261
159,075
11

NORTHERN IRELAND RHEUMATISM TRUST
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
14 Analysis of net assets between funds
Unrestricted
funds
2024
Restricted
funds
2024
Total
2024
At 31 Decernber 2024:
Current assetsl(liabilities)
170.809
5,832
176,641
170.809
5,832
176,641
Unrestricted
funds
2023
Restricted
funds
2023
Total
2023
At 31 December 2023:
Current assetsl(liabilities)
159,075
9.238
168.313
159,075
9,238
168,313
12-